Ask AI

Targeted Therapy TALK: Translating the Latest Advances into Precision Care for ALK-positive Advanced NSCLC

Deepen your understanding of ALK rearrangement biomarker testing and the latest data for managing patients with ALK-positive advanced NSCLC via expert-written ClinicalThought commentaries, downloadable slides, an on-demand webcast, and practical downloadable resources.

Share

Program Content

Activities

Testing and Treatment for ALK+ NSCLC
Best Practices in Testing and Treatment for Advanced ALK-Positive NSCLC and Overcoming Challenges to Implementation in Clinical Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2025

Expires: October 20, 2025

Activities

Managing ALK Positive NSCLC
Translating the Latest Advances Into Precision Care for Advanced ALK-Positive NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 02, 2025

Expires: November 01, 2025

Activities

Treating ALK+ NSCLC
Managing Advanced ALK-Positive Non-Small-Cell Lung Cancer: Considerations for Community Practitioners
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2025

Expires: September 26, 2025

ALK Inhibitor AEs
Identifying and Mitigating Adverse Events Associated With ALK Inhibitors for Advanced ALK-Positive Non-Small-Cell Lung Cancer
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2025

Expires: October 03, 2025

Patient Resource: ALK-Positive NSCLC
Patient Resource: Understanding Treatment Options for Advanced ALK-Positive NSCLC 
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2025

Expires: November 06, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.